2026/7/31
Presentation at BioProcessing Summit 2026
Ajinomoto Bio-Pharma Services will be attending and presenting at BioProcessing Summit 2026, from August 10 to 13, 2026.
At the Bioprocessing Summit, attendees explore cutting-edge science, share strategies with industry leaders, and address real-world challenges in bioprocess R&D, scale-up, quality, and analytics.
Under the “Oligonucleotide and Peptide CMC and Manufacturing” stream, we will present our innovative proprietary platform technologies AJIPHASE® and CORYNEX® and explain how it can be used to effectively manufacture oligos, peptides, VHHs, and conjugates.
We look forward to your visit.
| Event Name | BioProcessing Summit 2026 |
|---|---|
| Dates | August 10(Mon) – 13 (Thu), 2026 |
| Venue | Omni Boston Hotel at the Seaport |
| Exhibition | Oral Presentation, Poster Presentation |
Oral Presentation
| Topics and Presenters | “Oligo, Peptide, VHH, and Conjugate Manufacturing Using Ajiphase and Corynex” Yohei Yamada |
|---|---|
| Executive Summary | Ajiphase is Ajinomoto’s innovative liquid phase synthesis platform to manufacture ASOs, siRNAs, PMOs, PPMOs, and peptides. It is an eco-friendly method that enables mass production with high purity, and seamless scale up from lab to commercial. Corynex is our proprietary microbial secretion platform based on C. glutamicum that enables high-titer and high-purity production of various VHHs, peptides, and conjugates. It is very scalable, non-endotoxic, and doesn’t require refolding. |
| Date, Time and Venue | August 11(Tue) 3:35PM |
Poster Presentation
| Topics and Presenters | “Oligo, Peptide, VHH, and Conjugate Manufacturing Using Ajiphase and Corynex” Yohei Yamada |
|---|---|
| Executive Summary | Ajiphase is Ajinomoto’s innovative liquid phase synthesis platform to manufacture ASOs, siRNAs, PMOs, PPMOs, and peptides. It is an eco-friendly method that enables mass production with high purity, and seamless scale up from lab to commercial. Corynex is our proprietary microbial secretion platform based on C. glutamicum that enables high-titer and high-purity production of various VHHs, peptides, and conjugates. It is very scalable, non-endotoxic, and doesn’t require refolding. |
| Date, Time and Venue | August 10(Mon) evening – 12(Wed) morning |